Gene · 55512
Papers1,535
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,535
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Myristic Acid Remodels Sphingolipid Metabolism via Dual Pathways: Canonical d18-Sphingolipid Regulation and Non-Canonical d16-Sphingolipid Synthesis. | Nutrients | 2025 | 40944268 | PubTator, text mining | PubMed |
| Stem Cell-Derived Exosomes: A Comprehensive Review of Biomedical Applications, Challenges, and Future Directions. | Int J Nanomedicine | 2025 | 40933023 | PubTator, text mining | PubMed |
| KIF13B controls ciliary protein content by promoting endocytic retrieval and suppressing release of large extracellular vesicles from cilia. | Curr Biol | 2025 | 40930094 | PubTator, text mining | PubMed |
| Proinflammatory Stress Activates Neutral Sphingomyelinase 2-Based Generation of a Ceramide-Enriched β-Cell EV Subpopulation. | Diabetes | 2025 | 40896819 | PubTator, text mining | PubMed |
| Genome-Wide Association Study and Rare Variant Association Studies of Strabismus in the All of Us Research Program. | Ophthalmol Sci | 2025 | 40837069 | PubTator, text mining | PubMed |
| Targeting sphingolipid metabolism: inhibition of neutral sphingomyelinase 2 impairs coronaviral replication organelle formation. | mBio | 2025 | 40810514 | PubTator, text mining | PubMed |
| From laboratory to clinic: a precise treatment strategy of mesenchymal stem cells-derived exosomes pretreated by simulating disease microenvironment. | Front Immunol | 2025 | 40746527 | PubTator, text mining | PubMed |
| The role of exosomal PD-L1 in NSCLC immunotherapy. | Immunotherapy | 2025 | 40735784 | PubTator, text mining | PubMed |
| Sending the Signal to Bone: How Tumor-Derived EVs Orchestrate Pre-Metastatic Niche Formation and Skeletal Colonization. | Biomedicines | 2025 | 40722712 | PubTator, text mining | PubMed |
| Sulindac modulates the response of triple negative breast cancer to anti-PD-L1 immunotherapy. | bioRxiv | 2025 | 40666926 | PubTator, text mining | PubMed |
| The role of exosomes in immunopathology and potential therapeutic implications. | Cell Mol Immunol | 2025 | 40659888 | PubTator, text mining | PubMed |
| Neutral sphingomyelinase 2 inhibition alters inflammatory gene expression signatures in the brain of mice infected with West Nile virus. | Int Immunopharmacol | 2025 | 40652589 | PubTator, text mining | PubMed |
| Reduction of sphingomyelinase activity associated with progranulin deficiency and frontotemporal dementia. | Neurobiol Dis | 2025 | 40633679 | PubTator, text mining | PubMed |
| B lymphocytes impair osteogenesis by inhibiting BMSC differentiation in osteoporosis. | Immunobiology | 2025 | 40609267 | PubTator, text mining | PubMed |
| Precise nanoscale fabrication technologies, the "last mile" of medicinal development. | Acta Pharm Sin B | 2025 | 40487646 | PubTator, text mining | PubMed |
| Gastrointestinal acute radiation syndrome: current knowledge and perspectives. | Cell Death Discov | 2025 | 40368913 | PubTator, text mining | PubMed |
| Exploring lipid metabolism-associated gene biomarkers and their regulatory mechanisms in nasopharyngeal carcinoma. | Cancer Biomark | 2025 | 40294966 | PubTator, text mining | PubMed |
| Rare genetic variants involved in increased risk of paroxysmal atrial fibrillation in a Japanese population. | Sci Rep | 2025 | 40240483 | PubTator, text mining | PubMed |
| Novel Pyrazolo[1,5-a]pyrimidine-3,5-diamines as nSMase2 Inhibitors. | ACS Med Chem Lett | 2025 | 40236526 | PubTator, text mining | PubMed |
| The Ceramide-Dependent EV Secretome Differentially Affects Prostate Cancer Cell Migration. | Cells | 2025 | 40214501 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55512/papers?page=3